Literature DB >> 4416300

The immunologic and neurohormonal regulation of bronchial asthma.

L D Robinson, M Lenoir.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4416300      PMCID: PMC2609253     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  7 in total

Review 1.  The clinical significance of IgE.

Authors:  S G Johansson; H H Bennich; T Berg
Journal:  Prog Clin Immunol       Date:  1972

Review 2.  Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug.

Authors:  J S Cox
Journal:  Br J Dis Chest       Date:  1971-10

3.  Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients.

Authors:  D Y Yu; S P Galant; W M Gold
Journal:  J Appl Physiol       Date:  1972-06       Impact factor: 3.531

4.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Immunoglobulin E. A new class of human immunoglobulin.

Authors:  H H Bennich; K Ishizaka; S G Johansson; D S Rowe; D R Stanworth; W D Terry
Journal:  Immunochemistry       Date:  1968-07

6.  Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP.

Authors:  R P Orange; M A Kaliner; P J Laraia; K F Austen
Journal:  Fed Proc       Date:  1971 Nov-Dec

7.  Cromolyn treatment of asthmatic children.

Authors:  W L McLean; J Lozano; P Hannaway; S Sakowitz; H L Mueller
Journal:  Am J Dis Child       Date:  1973-03
  7 in total
  1 in total

1.  Outpatient management of the asthmatic child.

Authors:  M A LeNoir; L D Robinson
Journal:  J Natl Med Assoc       Date:  1976-01       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.